# Novartis

瑞士制药巨头——CAR-T疗法先驱（Kymriah）和抗体重磅药Cosentyx；临床和商业生物制品的大型CDMO客户；SIX: NOVN。

Source: https://cn.bioecon.ru/companies/novartis/
Updated: 2026-06-19

- 国家: Switzerland
- 营收: $52.7B
- 员工: ~78,000 emp

## 可核验事实

| 事实 | 数值 | 来源 |
| --- | --- | --- |
| 生产基地 | 全球33个生产基地 | https://prod1.novartis.com/sites/novartis_com/files/novartis-integrated-report-2024.pdf, https://www.novartis.com/ch-de/sites/novartis_ch/files/novartis-in-switzerland-2024.pdf |
| 员工人数 | 全球75,883人（2024年） | https://www.novartis.com/ch-de/sites/novartis_ch/files/novartis-in-switzerland-2024.pdf |
| 认证 | 通过ISO 9001认证；所有生产运营均通过cGMP认证 | https://www.novartis.com/about/quality/novartis-quality-management-system-qms, https://www.novartis.com/sites/novartis_com/files/novartis-bsi-iso-9001-certificate-fs-771945.pdf |
| 监管批准 | 受FDA、EMA、世卫组织及瑞士药管局等机构监管与检查 | https://www.novartis.com/about/quality/audit-program-and-regulatory-inspections, https://www.novartis.com/about/quality/novartis-quality-management-system-qms |
| 产能 | 大规模生物制品、CAR-T、放射性配体疗法及小分子生产产能；目标为2030年前实现100%端到端美国本土生产 [中等置信度] | https://www.biopharmadive.com/news/novartis-car-t-kymriah-manufacturing-production-challenges/504017/, https://www.bioprocessintl.com/facilities-capacity/swiss-site-opens-to-boost-novartis-car-t-production, https://www.novartis.com/ch-de/sites/novartis_ch/files/novartis-in-switzerland-2024.pdf |
| 融资 | 计划2025-2029年在美国基础设施投资$230亿 | https://www.novartis.com/us-en/news/media-releases/novartis-plans-expand-its-us-based-manufacturing-and-rd-footprint-total-investment-23b-over-next-5-years, https://www.sec.gov/Archives/edgar/data/1114448/000111444826000008/a260204-99_1.pdf |

独立来源: biopharmadive.com, bioprocessintl.com, sec.gov

## 技术

- [CAR-T 细胞疗法](https://cn.bioecon.ru/technology/car-t-cell-therapy/)
- [个性化与再生医学](https://cn.bioecon.ru/technology/personalized-regenerative-medicine/)
- [企业生物技术加速器（JLABS、拜耳CoLaborator）](https://cn.bioecon.ru/technology/corporate-biotech-accelerators/)
- [体内基因治疗：AAV与慢病毒载体](https://cn.bioecon.ru/technology/gene-therapy-in-vivo-aav-lentiviral/)
- [放射性药物与诊疗一体化](https://cn.bioecon.ru/technology/radiopharmaceuticals-theranostics/)
- [生物药 (Biologics)](https://cn.bioecon.ru/technology/biologics/)
